Martin Shkreli, the Turing Pharmaceutical chief executive reviled for jacking up drug prices, doesn't want to talk about drug prices anymore.
But he does want to be heard.
The so-called "most hated man in America" wanted to appear Thursday on CNBC to defend rival Valeant Pharmaceuticals against a short-selling firm's report accusing the company of Enron-like accounting fraud. But when producers said they wanted to probe him about drug prices, too, he refused to go on air.
Scott Wapner, the host of CNBC's "Halftime Report," tweeted the story:
.@MartinShkreli wanted to come on @CNBC to defend $VRX. We said have to talk RX prices too. He said no. We said see ya. Tells u all u need..
— Scott Wapner (@ScottWapnerCNBC) October 22, 2015
This is the same @MartinShkreli who also insulted our star healthcare reporter @megtirrell on Twitter. I guess that tells you more...
— Scott Wapner (@ScottWapnerCNBC) October 22, 2015
His bait and switch thing is compete BS. What news organization would put that guy on and NOT ask about drug prices? Find me one.
— Scott Wapner (@ScottWapnerCNBC) October 22, 2015
Instead, it appears that Shkreli took his interview to Fox Business Network, Fox News' business and finance branch that has struggled to compete with CNBC for viewers.
Will be on Fox Business News tomorrow, exclusively, with Maria Bartiromo @MariaBartiromo .
— Martin Shkreli (@MartinShkreli) October 22, 2015
CNBC @CNBC asks me to come on and talk $VRX. then they tell me they want to talk Turing. i tell them to pound sand. pic.twitter.com/z5RSXcvCwv
— Martin Shkreli (@MartinShkreli) October 22, 2015
It remains unclear why his opinion on the subject is worth pursuing. However, it's bound to be entertaining television.
No comments:
Post a Comment